BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » iPSC » Page 14

Technical Attributes You Need to Know Invest in the Induced Pluripotent Stem Cell (iPSC) Market

March 9, 2015 By Cade Hildreth (CEO) Leave a Comment

Induced Pluripotent Stem Cell iPSC Investment Market

If you are an investor considering an opportunity related to induced pluripotent stem cells (iPSCs), the market can initially appear technical and confusing. However, if you focus on a few key points of understanding, you’ll be able to assess the technical attributes that matter, including what defines the cell type, advantages and disadvantages, key events driving market growth, and opportunities for commercialization.

To begin, the best place to start is with a clear definition of the cell type.

Definition of Induced Pluripotent Stem Cells

Induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cell artificially derived from a non-pluripotent cell – typically an adult somatic cell, by inducing a ‘forced’ expression of specific gene. [Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: induced pluripotent stem cells, investors, iPSC, market, stem cells

Induced Pluripotent Stem Cell News Round-Up| February 22 – 28, 2015

February 28, 2015 By Cade Hildreth (CEO) Leave a Comment

iPSC News Round-Up

“Supreme Court Rules on Stem Cells, $100 Billion Proposed for International Stem Cell Collaboration, Japan to Launch iPSC Therapy Center, and More”

Induced pluripotent stem cells (iPSCs) are a rapidly evolving area of stem cell science. Since the discovery of the cell type in 2006, there have been several important market events, including the first ever clinical trial in humans which launched in August of 2013 to evaluate the capacity of iPSC-derived cell sheets for their ability to restore vision in patients with wet-type macular degeneration. More recently, the Supreme Court rejected the right of the Wisconsin Alumni Research Foundation (WARF) to control patents related to iPSC derivation in a landmark patent decision issued in February 2015.
[Read more…]

Filed Under: iPS Cells Tagged With: iPSC, market update, stem cells, therapies

Induced Pluripotent Stem Cell (iPSC) News Round-Up| February 2015

February 28, 2015 By Cade Hildreth (CEO) Leave a Comment

iPSC News Round-Up

“Supreme Court Rules on Stem Cells, $100 Billion Proposed for International Stem Cell Collaboration, Japan to Launch iPSC Therapy Center, and More”

Induced pluripotent stem cells (iPSCs) are a rapidly evolving area of stem cell science. Since the discovery of the cell type in 2006, there have been several important market events, including the first ever clinical trial in humans which launched in August of 2013 to evaluate the capacity of iPSC-derived cell sheets for their ability to restore vision in patients with wet-type macular degeneration. More recently, the Supreme Court rejected the right of the Wisconsin Alumni Research Foundation (WARF) to control patents related to iPSC derivation in a landmark patent decision issued in February 2015. [Read more…]

Filed Under: iPS Cells Tagged With: iPSC, market update, stem cells, therapies

Induced Pluripotent Stem Cell News Round-Up| February 15-22, 2015

February 20, 2015 By Cade Hildreth (CEO) Leave a Comment

iPSC News Round-Up February 2014

The induced pluripotent stem cell (iPSC) industry is a rapidly evolving area.  Since the discovery of iPSCs in 2006, there have been a number of important market events that have occurred, including the first ever clinical trial in humans that was initiated in August 2013 to investigate iPSC-derived cell sheets for restoring vision, as well as large funding awards, major initial public offerings (IPOs), critical patent challenges, and more. [Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: cell therapy, current events, iPSC, market update, stem cells

Induced Pluripotent Stem Cell (iSPC) News Round-Up| January 2015

February 20, 2015 By Cade Hildreth (CEO) Leave a Comment

iPSC News Round-Up February 2014

The induced pluripotent stem cell (iPSC) industry is a rapidly evolving area.  Since the discovery of iPSCs in 2006, there have been a number of important market events that have occurred, including the first ever clinical trial in humans that was initiated in August 2013 to investigate iPSC-derived cell sheets for restoring vision, as well as large funding awards, major initial public offerings (IPOs), critical patent challenges, and more. [Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: cell therapy, current events, iPSC

  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • Next Page »

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.